These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 24261789)

  • 1. Coix lacryma-jobi associated symmetrical drug-related intertriginous and flexural exanthema.
    Choi MJ; Oh SH; Cho SB
    Int J Dermatol; 2014 Apr; 53(4):e301-3. PubMed ID: 24261789
    [No Abstract]   [Full Text] [Related]  

  • 2. Symmetrical drug-related intertriginous and flexural exanthema like eruption associated with COVID-19 vaccination.
    Lim PN; Wylie G
    Clin Exp Dermatol; 2022 Jan; 47(1):175-176. PubMed ID: 34399001
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Symmetrical drug-related intertriginous and flexural exanthema (SDRIFE) associated with pristinamycin, secnidazole, and nefopam, with a review of the literature.
    Nespoulous L; Matei I; Charissoux A; Bédane C; Assikar S
    Contact Dermatitis; 2018 Dec; 79(6):378-380. PubMed ID: 30062790
    [No Abstract]   [Full Text] [Related]  

  • 4. Docetaxel-induced symmetrical drug-related intertriginous and flexural exanthema (SDRIFE) confirmed by skin testing.
    Hampel A; Kinaciyan T
    Contact Dermatitis; 2024 May; 90(5):525-527. PubMed ID: 38263696
    [No Abstract]   [Full Text] [Related]  

  • 5.
    Cabrera Hernandez V; Gonzalez Afonso M; Callero Viera A; Martin-Fernandez Martin L
    BMJ Case Rep; 2019 Aug; 12(8):. PubMed ID: 31377719
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intertriginous eruption induced by terbinafine: a review of baboon syndrome.
    Janjua SA; Pastar Z; Iftikhar N; Ammad S
    Int J Dermatol; 2017 Jan; 56(1):100-103. PubMed ID: 27153516
    [No Abstract]   [Full Text] [Related]  

  • 7. Symmetrical drug-related intertriginous and flexural exanthema caused by valacyclovir.
    Daito J; Hanada K; Katoh N; Katoh S; Sakamoto K; Asai J; Takenaka H; Kishimoto S
    Dermatology; 2009; 218(1):60-2. PubMed ID: 18974630
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A systematic approach to systemic contact dermatitis and symmetric drug-related intertriginous and flexural exanthema (SDRIFE): a closer look at these conditions and an approach to intertriginous eruptions.
    Winnicki M; Shear NH
    Am J Clin Dermatol; 2011 Jun; 12(3):171-80. PubMed ID: 21469762
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Three cases of symmetrical drug-related intertriginous and flexural exanthema (SDRIFE) induced by proton-pump inhibitors.
    Spigariolo CB; Barei F; Maronese CA; Barberi F; Cattaneo A; Violetti SA
    Australas J Dermatol; 2022 Nov; 63(4):509-512. PubMed ID: 35877187
    [TBL] [Abstract][Full Text] [Related]  

  • 10. First case of symmetrical drug-related intertriginous and flexural exanthema (SDRIFE) due to Berberine, an over-the-counter herbal glycemic control agent.
    Labadie JG; Florek AG; Croitoru A; Liu W; Krunic AL
    Int J Dermatol; 2018 Sep; 57(9):e68-e70. PubMed ID: 29808929
    [No Abstract]   [Full Text] [Related]  

  • 11. Pustulobullous variant of SDRIFE (symmetrical drug-related intertriginous and flexural exanthema).
    Magnolo N; Metze D; Ständer S
    J Dtsch Dermatol Ges; 2017 Jun; 15(6):657-659. PubMed ID: 28514083
    [No Abstract]   [Full Text] [Related]  

  • 12. Symmetrical drug-related intertriginous and flexural exanthema secondary to topical 5-fluorouracil.
    Powers R; Gordon R; Roberts K; Kovach R
    Cutis; 2012 May; 89(5):225-8. PubMed ID: 22768435
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Symmetrical drug-related intertriginous and flexural exanthema due to codeine.
    Erfan G; Yanik ME; Kaya S; Tasolar K; Oznur M; Kulac M
    Indian J Dermatol Venereol Leprol; 2015; 81(4):405-6. PubMed ID: 26087105
    [No Abstract]   [Full Text] [Related]  

  • 14. Symmetric drug-related intertriginous and flexural exanthema: Clinicopathologic study of 19 cases and review of literature.
    Schuler AM; Smith EH; Chaudet KM; Bresler SC; Gudjonsson JE; Kroshinsky D; Nazarian RM; Chan MP
    J Cutan Pathol; 2021 Dec; 48(12):1471-1479. PubMed ID: 34159622
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clozapine-induced symmetrical drug-related intertriginous and flexural exanthema: first reported cases.
    Rao A; Francis N; Morar N
    Br J Dermatol; 2012 May; 166(5):1142-3. PubMed ID: 22121994
    [No Abstract]   [Full Text] [Related]  

  • 16. Symmetrical drug-related intertriginous and flexural exanthema/baboon syndrome induced by traditional Chinese medicine.
    Liu J; Li LF
    J Cosmet Dermatol; 2022 May; 21(5):2200-2204. PubMed ID: 34333850
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Paracetamol-induced symmetrical drug-related intertriginous and flexural exanthema (SDRIFE) in a psoriasis patient receiving apremilast therapy.
    Megna M; Cinelli E; Napolitano M; Fabbrocini G; Patruno C
    Contact Dermatitis; 2019 Dec; 81(6):451-454. PubMed ID: 31328275
    [No Abstract]   [Full Text] [Related]  

  • 18. First case of symmetric drug-related intertriginous and flexural exanthema (sdrife) due to rivastigmine?
    Allain-Veyrac G; Lebreton A; Collonnier C; Jolliet P
    Am J Clin Dermatol; 2011 Jun; 12(3):210-3. PubMed ID: 21469764
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sebotropic eruption associated with use of oral kava kava supplement.
    Huynh JC; Asgari MM; Moore MM
    Clin Exp Dermatol; 2014 Oct; 39(7):816-8. PubMed ID: 25214405
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Symmetrical drug-related intertriginous and flexural exanthema due to ranitidine.
    Binitha MP; Sasidharanpillai S; John R; Sherjeena PV
    Indian J Pharmacol; 2014; 46(5):551-2. PubMed ID: 25298589
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.